Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease
Public ClinicalTrials.gov record NCT00277810. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Safety, Tolerability, and Efficacy Study of 3 Doses of Lecozotan (SRA-333) SR in Outpatients With Mild to Moderate Alzheimer's Disease Treated With a Cholinesterase Inhibitor
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to determine the safety, tolerability, and efficacy of 3 doses of lecozotan in combination with a cholinesterase inhibitor in patients with mild to moderate Alzheimer's disease (AD).
Study identification
- NCT ID
- NCT00277810
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2006 (Type not available)
- Primary completion
- Jun 2008 (Actual)
- Completion
- Jun 2008 (Actual)
- Last update posted
- Jul 7, 2020
2006 – 2008
United States locations
- U.S. sites
- 33
- U.S. states
- 14
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85013 | — |
| Not listed | Tucson | Arizona | 85741 | — |
| Not listed | Costa Mesa | California | 92626 | — |
| Not listed | Fresno | California | 93720 | — |
| Not listed | La Jolla | California | 92037 | — |
| Not listed | Orange | California | 92868 | — |
| Not listed | Delray Beach | Florida | 33445 | — |
| Not listed | Fort Lauderdale | Florida | 33321 | — |
| Not listed | Fort Myers | Florida | 33916 | — |
| Not listed | Hallandale | Florida | 33009 | — |
| Not listed | Hialeah | Florida | 33016 | — |
| Not listed | Jacksonville | Florida | 33216 | — |
| Not listed | Miami | Florida | 33176 | — |
| Not listed | Miami Beach | Florida | 33154 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Sarasota | Florida | 34239 | — |
| Not listed | South Miami | Florida | 33143 | — |
| Not listed | Tampa | Florida | 33617 | — |
| Not listed | West Palm Beach | Florida | 33407 | — |
| Not listed | St Louis | Missouri | 63104 | — |
| Not listed | Long Branch | New Jersey | 07740 | — |
| Not listed | Manchester Twp. | New Jersey | 08759 | — |
| Not listed | Albany | New York | 12208 | — |
| Not listed | Cedarhurst | New York | 11516 | — |
| Not listed | Staten Island | New York | 10312 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Columbus | Ohio | 43210 | — |
| Not listed | Tulsa | Oklahoma | 74104 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | East Providence | Rhode Island | 02914 | — |
| Not listed | Memphis | Tennessee | 38119 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Bennington | Vermont | 05201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00277810, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2020 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00277810 live on ClinicalTrials.gov.